Adjuvant cytokeratin staining in Mohs micrographic surgery for basal cell carcinoma

Dermatologic Surgery

Volumn 29, Issue 4, 2003, Pages 375-377

  Smeets, Nicole W J ^a   Stavast Kooy, Angela J W ^b   Krekels, Gertruud A M ^a   Daemen, Mat J A P ^a   Neumann, H A Martino ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; EOSIN; HEMATOXYLIN; MONOCLONAL ANTIBODY; TUMOR MARKER;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CHEMOSURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CARCINOMA, BASAL CELL; COLORING AGENTS; EOSINE YELLOWISH-(YS); FROZEN SECTIONS; HEMATOXYLIN; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MIDDLE AGED; MOHS SURGERY; SKIN NEOPLASMS;

EID: 0344406766     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2003.29089.x     Document Type: Article

References (18)

1. Gaston DA, Naugle C, Clark DP. Mohs micrographic surgery referral patterns: the University of Missouri experience. Dermatol Surg 1999;25:862-6.
2. Julian CG, Bowers PW. A prospective study of Mohs' micrographic surgery in two English centres. Br J Dermatol 1997;136:515-8.
3. Wennberg AM, Larko O, Stenquist B. Five-year results of Mohs' micrographic surgery for aggressive facial basal cell carcinoma in Sweden. Acta Derm Venereol 1999;79:370-2.
4. Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999;135:1177-83.
5. Rowe DE, Carroll RJ, Day CL. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989;15:315-28.
6. Rowe DE, Carroll RJ, Day CL. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989;15:424-31.
7. Shriner DL, McCoy DK, Goldberg DJ, Wagner RF. Mohs micrographic surgery. J Am Acad Dermatol 1998;39:79-97.
8. Abide JM, Nahai F, Bennett RG. The meaning of surgical margins. Plast Reconstr Surg 1984;73:492-7.
9. Katz KH, Helm KF, Billingsley EM, Maloney ME. Dense inflammation does not mask residual primary basal cell carcinoma during Mohs micrographic surgery. J Am Acad Dermatol 2001;45:231-8.
10. Jimenez FJ, Grichnik JM, Buchanan MD, Clark RE. Immunohistochemical techniques in Mohs micrographic surgery: their potential use in the detection of neoplastic cells masked by inflammation. J Am Acad Dermatol 1995;32:89-94.
11. Zachary CB, Perkins W. Rapid immunoenzyme Mohs technique for skin cancer removal: advances in Mohs surgery. Facial Plast Surg Clin North Am 1998;6:337-45.
12. Zachary CB, Rest EB, Furlong SM, Arcedo PN, McGeorge BC, Kist DA. Rapid cytokeratin stains enhance the sensitivity of Mohs micrographic surgery for squamous cell carcinoma. J Dermatol Surg Oncol 1994;20:530-5.
13. Mondragon RM, Barrett TL. Current concepts: the use of immunoperoxidase techniques in Mohs micrographic surgery. J Am Acad Dermatol 2000;43(1 Pt 1):66-71.
14. Ramnarain ND, Walker NP, Markey AC. Basal cell carcinoma: rapid techniques using cytokeratin markers to assist treatment by micrographic (Mohs') surgery. Br J Biomed Sci 1995;52:184-7.
15. Prieto VG, Lugo J, McNutt NS. Intermediate- and low-molecular-weight keratin detection with the monoclonal antibody MNF116: an immunohistochemical study on 232 paraffin-embedded cutaneous lesions. J Cutan Pathol 1996;23:234-41.
16. Cattoretti G, Berti E, Schiro R, D'Amato L, Valeggio C, Rilke F. Improved avidin-biotin-peroxidase complex (ABC) staining. Histochem J 1988;20:75-80.
17. De Silva SP, Dellon AL. Recurrence rate of positive margin basal cell carcinoma: results of a five-year prospective study. J Surg Oncol 1985;28:72-4.
18. Sussman LA, Liggins DE Incompletely excised basal cell carcinoma: a management dilemma? Aust N Z J Surg 1996;66:276-8.